Question

Difficulty: MediumHematology and Oncology

A 26-year-old woman, gravida 1, para 0, comes to the clinic for a routine prenatal visit at 24 weeks gestation. She reports mild, intermittent fatigue at the end of the day but is otherwise feeling well. She has no significant past medical history and takes a daily prenatal vitamin containing folic acid and a standard dose of iron. Her blood pressure is 112/70 mmHg, pulse is 80/min, and respiratory rate is 14/min. Physical examination shows a gravid uterus consistent with dates and normal fetal heart tones. There is no conjunctival pallor or scleral icterus. Laboratory studies are obtained and reveal the following:

Laboratory TestResult
Hemoglobin10.7 g/dL
Hematocrit32%
Mean corpuscular volume (MCV)88 fL
White blood cell count8,500/mm³
Platelets230,000/mm³

Which of the following is the most appropriate next step in management for this patient's hematologic findings?

  1. Reassurance and continuation of routine prenatal careAnswer
  2. B
    Initiation of oral ferrous sulfate therapy
  3. C
    Measurement of serum ferritin and total iron-binding capacity
  4. D
    Peripheral blood smear evaluation
  5. E
    Hemoglobin electrophoresis

Answer

Reassurance and continuation of routine prenatal care
The correct answer is reassurance and continuation of routine prenatal care. This patient's laboratory results demonstrate the normal physiologic changes of pregnancy, often referred to as 'physiologic anemia of pregnancy.' During pregnancy, maternal plasma volume expands by approximately 40-50% to accommodate the growing fetus and increase perfusion to the uterus. While the total red blood cell (RBC) mass also increases (by about 20-30%), the plasma volume expansion is disproportionately larger. This results in a dilutional effect, lowering the hemoglobin concentration and hematocrit. Because this hemodilution peaks late in the second trimester (around 24-28 weeks), the threshold for defining true anemia changes. According to standard clinical guidelines, anemia in pregnancy is defined as a hemoglobin level < 11.0 g/dL in the first and third trimesters, and < 10.5 g/dL in the second trimester. At 24 weeks gestation, this patient's hemoglobin of 10.7 g/dL is within the normal range. Her MCV is also completely normal (88 fL). Therefore, no pathological anemia is present, and she does not require additional iron supplementation beyond her standard prenatal vitamin, nor does she need further hematologic diagnostic testing.

Step-by-Step Solution

1
Analyze the patient's complete blood count in the context of her pregnancy timeline (24 weeks gestation).
The hemoglobin is 10.7 g/dL, which is above the second-trimester diagnostic threshold for anemia (< 10.5 g/dL).
Pregnancy alters the normal reference ranges for hematologic parameters; assessing labs against standard non-pregnant ranges will lead to misdiagnosis.
2
Determine the pathophysiology of the mild decrease in hemoglobin compared to the non-pregnant state.
The decrease is due to a disproportionate increase in maternal plasma volume relative to red blood cell mass.
This physiologic hemodilution peaks late in the second trimester, artificially lowering the hemoglobin concentration and hematocrit.
3
Select the appropriate clinical intervention based on the findings.
No further diagnostic workup or specific pharmacologic treatment is required.
The hematologic findings represent the normal, expected physiologic changes of a healthy pregnancy.

Key Concept

Physiologic anemia of pregnancy and trimester-specific hemoglobin thresholds
Estimated Time:1m 15s
Rate this question